2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole

C28H22F6N5O6S3- — CID 90056779

IUPAC2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole
SMILESCOCc1ccc(-c2ccc3nc(C(c4cc(C(F)(F)F)cc(C(F)(F)F)c4)(c4nnc(CNNS(=O)[O-])o4)S(C)(=O)=O)sc3c2)cc1
InChIInChI=1S/C28H23F6N5O6S3/c1-44-14-15-3-5-16(6-4-15)17-7-8-21-22(9-17)46-25(36-21)26(48(2,42)43,24-38-37-23(45-24)13-35-39-47(40)41)18-10-19(27(29,30)31)12-20(11-18)28(32,33)34/h3-12,35,39H,13-14H2,1-2H3,(H,40,41)/p-1
InChIKeyOXZRDPURVBBXRJ-UHFFFAOYSA-M
MW734.70 g/mol
LogP5.26
Rot. Bonds11

About 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole

2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole (PubChem CID 90056779) has the molecular formula C28H22F6N5O6S3- and a molecular weight of 734.70 g/mol. Its IUPAC name is 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole
PubChem CID90056779
Molecular FormulaC28H22F6N5O6S3-
Molecular Weight734.70 g/mol
Exact Mass734.06
IUPAC Name2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole
SMILESCOCc1ccc(-c2ccc3nc(C(c4cc(C(F)(F)F)cc(C(F)(F)F)c4)(c4nnc(CNNS(=O)[O-])o4)S(C)(=O)=O)sc3c2)cc1
InChIInChI=1S/C28H23F6N5O6S3/c1-44-14-15-3-5-16(6-4-15)17-7-8-21-22(9-17)46-25(36-21)26(48(2,42)43,24-38-37-23(45-24)13-35-39-47(40)41)18-10-19(27(29,30)31)12-20(11-18)28(32,33)34/h3-12,35,39H,13-14H2,1-2H3,(H,40,41)/p-1
InChIKeyOXZRDPURVBBXRJ-UHFFFAOYSA-M
XLogP5.26
TPSA159.37 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds11
Heavy Atoms48
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500734.70
LogP ≤ 55.26
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'sulfinic_acid', 'substructure': 'N/A'}

Analyze 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole?
The IUPAC name of 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole (CID 90056779) is 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole is COCc1ccc(-c2ccc3nc(C(c4cc(C(F)(F)F)cc(C(F)(F)F)c4)(c4nnc(CNNS(=O)[O-])o4)S(C)(=O)=O)sc3c2)cc1.
What is the InChIKey of 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole?
The InChIKey is OXZRDPURVBBXRJ-UHFFFAOYSA-M. The full InChI is InChI=1S/C28H23F6N5O6S3/c1-44-14-15-3-5-16(6-4-15)17-7-8-21-22(9-17)46-25(36-21)26(48(2,42)43,24-38-37-23(45-24)13-35-39-47(40)41)18-10-19(27(29,30)31)12-20(11-18)28(32,33)34/h3-12,35,39H,13-14H2,1-2H3,(H,40,41)/p-1.
What are the key properties of 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole?
2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole has a molecular weight of 734.70 g/mol, XLogP of 5.26, 11 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[3,5-bis(trifluoromethyl)phenyl]-[6-[4-(methoxymethyl)phenyl]-1,3-benzothiazol-2-yl]-methylsulfonylmethyl]-5-[(2-sulfinatohydrazinyl)methyl]-1,3,4-oxadiazole is sourced from PubChem (CID 90056779), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).